King Pharmaceuticals KG Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net premiums earned by Business | ||||||
| AmTrust Legacy Segment | $2.29M— | —— | $2.96M— | $1.03M— | —— | |
| Diversified Legacy Segment | $867K— | —— | $3.88M— | $1.39M— | —— | |
| Legacy Reinsurance | $3.16M— | $3.42M— | $6.84M— | $2.42M— | $0— | |
| Net premiums written by Business | ||||||
| AmTrust Legacy Segment | $1.88M— | —— | $308K— | -$285K— | —— | |
| Diversified Legacy Segment | $775K— | —— | $3.59M— | $1.38M— | —— | |
| Legacy Reinsurance | $2.65M— | $1.22M— | $3.9M— | $1.1M— | $0— | |
| Total AmTrust Reinsurance PPD by Business | ||||||
| AmTrust Reinsurance legacy business | -$551K— | -$1.65M— | -$6.91M— | —— | —— | |
| Diversified Legacy Reinsurance | $274K— | $634K— | $291K— | —— | —— | |
| Reinsurance recoverable, allowance for credit loss by Business | ||||||
| AmTrust Reinsurance legacy business | $1.23M— | $1.05M— | $695K— | $707K— | —— | |
| Diversified Legacy Reinsurance | $700K— | $689K— | $598K— | $780K— | —— | |
| Total AmTrust Reinsurance PPD by Product | ||||||
| AmTrust Quota Share | -$370K— | -$6.36M— | $1.4M— | —— | —— | |
| European Hospital Liability Quota Share | -$2K— | $9.13M— | -$4.71M— | —— | —— | |
| LPT/ADC Agreement | -$179K— | -$4.42M— | -$3.6M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does King Pharmaceuticals break its business down?
- King Pharmaceuticals (KG) reports net premiums earned by business across 4 parts — AmTrust Legacy Segment, AmTrust Reinsurance, Diversified Legacy Segment and Legacy Reinsurance. Each is extracted from the segment footnotes and tracked over time.
- Where does King Pharmaceuticals's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in King Pharmaceuticals's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
